-
Story /Our Global Head of Patient Affairs and Policy shares why it’s critical to engage patients throughout the drug development process.
-
Story /Meet our Vice President of Strategic Data and Digital at Novartis Oncology.
-
Featured News /
Cell Therapies Pty Ltd has become the first approved CAR-T commercial manufacturing site in Australia, providing potentially faster access to CAR-T therapies to eligible patients in the region with life-threatening blood cancers.
Novartis global commercial CAR-T manufacturing footprint now spans four continents, bringing these transformative therapies closer to patients and healthcare professionals around the world. -
Story /By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs
-
Story / -
Story /Novel digital platform for clinical trial data collection could help facilitate much-needed biomedical research in lower-income countries.
-
Story / -
Story /Experts call for significant changes to facilitate the discovery of new treatments.
-
Featured News /
Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond, a first in the healthcare industry.
-
Story /New head of oncology research hopes to build on recent advances, explore new therapeutic approaches and beat certain cancers for good.